GSK plc (LON:GSK) Receives Consensus Rating of “Hold” from Analysts

Shares of GSK plc (LON:GSKGet Free Report) have been assigned a consensus rating of “Hold” from the seven ratings firms that are covering the stock, reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is GBX 1,675.63 ($21.47).

GSK has been the topic of a number of research reports. Berenberg Bank upped their target price on GSK from GBX 1,650 ($21.14) to GBX 1,820 ($23.32) and gave the company a “buy” rating in a report on Wednesday, February 14th. Shore Capital restated a “buy” rating on shares of GSK in a report on Wednesday, May 1st. Barclays restated an “equal weight” rating and issued a GBX 1,725 ($22.10) price objective on shares of GSK in a report on Tuesday, May 7th. JPMorgan Chase & Co. restated an “underweight” rating on shares of GSK in a report on Tuesday, June 4th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 1,950 ($24.98) price objective on shares of GSK in a report on Wednesday, April 17th.

Check Out Our Latest Research Report on GSK

Insider Buying and Selling at GSK

In related news, insider Urs Rohner purchased 434 shares of the stock in a transaction on Wednesday, March 20th. The shares were bought at an average price of GBX 1,662 ($21.29) per share, for a total transaction of £7,213.08 ($9,241.61). Corporate insiders own 1.60% of the company’s stock.

GSK Price Performance

Shares of GSK opened at GBX 1,617.50 ($20.72) on Monday. The company has a market capitalization of £65.99 billion, a price-to-earnings ratio of 1,494.50, a P/E/G ratio of 1.19 and a beta of 0.27. GSK has a fifty-two week low of GBX 1,302.60 ($16.69) and a fifty-two week high of GBX 1,823.50 ($23.36). The company has a debt-to-equity ratio of 134.34, a current ratio of 0.87 and a quick ratio of 0.73. The business’s 50-day moving average is GBX 1,695.52 and its 200-day moving average is GBX 1,614.83.

GSK Cuts Dividend

The business also recently declared a dividend, which will be paid on Thursday, July 11th. Shareholders of record on Thursday, May 16th will be issued a dividend of GBX 15 ($0.19) per share. The ex-dividend date is Thursday, May 16th. This represents a yield of 0.9%. GSK’s dividend payout ratio (DPR) is presently 5,504.59%.

GSK Company Profile

(Get Free Report

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.

Read More

Analyst Recommendations for GSK (LON:GSK)

Receive News & Ratings for GSK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GSK and related companies with's FREE daily email newsletter.